TWST vs WY · rev $332.8M vs P/E 43, rev $3.59B
Twist Bioscience Corp (TWST) versus Weyerhaeuser Company (WY) — a side-by-side from cached financials, not a winner call.
Twist Bioscience Corp (TWST) is a diagnostics & research company listed on NASDAQ.
Weyerhaeuser Company (WY) is a reit - specialty company listed on NYSE.
Latest reported TWST revenue for 2026-06-30 was $332.8M. Net income was -$109.6M. Revenue was up 55.2% from 2026-03-31 to 2026-06-30. TWST currently screens at market cap $5.16B.
Latest reported WY revenue for 2026-06-30 was $3.59B. Net income was $318.0M. WY currently screens at market cap $17.54B and trailing P/E 43.4.
TWST currently screens at market cap $5.16B. WY currently screens at market cap $17.54B and trailing P/E 43.4.
Not investment advice. Open the TWST and WY stock pages for the full models.
Not investment advice.